Roundhill Glp-1 & Weight Loss ETF (OZEM US) stock market data APIs
31.1398
0(0%)
as of September 18, 2026
Try our APIs with
free plan!
Roundhill Glp-1 & Weight Loss ETF Financial Data Overview
Price chart is built with
Anychart
Prev. Close
31.1398
Open
31.1423
High
31.1456
Low
31.1385
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Roundhill Glp-1 & Weight Loss ETF data using free add-ons & libraries
End-of-day & Earnings data
Get Roundhill Glp-1 & Weight Loss ETF Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Roundhill Glp-1 & Weight Loss ETF News
New
Two Drugmakers Own 90% of the Obesity Boom. One Fund Owns Both for 0.59%
Quick Read OZEM holds Lilly at 16% and Novo Nordisk at 13%, concentrating nearly 30% in GLP-1 leaders versus XLV's diluted multi-sector exposure. OZEM rounds out its GLP-1 core with Pfizer at 8% and ...
Weight Loss ETFs Poised to Rally as Medicare Greenlights GLP-1 Coverage
In a landmark move beginning July 1, 2026, Medicare, under its "GLP-1 Bridge" demonstration program, is set to provide eligible U.S. seniors with access to popular weight-loss medications like Wegovy,...
Medicare GLP-1 Bridge: What to expect
[Injectable semaglutide pens for glucose control with a blue measuring tape on a clean background for weight loss and medical themes.] Eduardo Monroy Husillos/iStock via Getty Images Millions of Amer...
3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend
Key Points Interested in Teladoc Health, Inc.? Here are five stocks we like better. With the GLP-1 agonist market still growing at a rapid pace, companies outside of the pharma industry are increasin...
Get Roundhill Glp-1 & Weight Loss ETF fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
